FORLENZA JOSEPH M 4

4 · SEACOAST BANKING CORP OF FLORIDA · Filed Feb 27, 2026

AI-generated summary of this filing

Updated Feb 27, 2026

Seacoast Banking EVP Joseph Forlenza Exercises Options, Sells Shares

What Happened

Joseph M. Forlenza, EVP & Chief Risk Officer of Seacoast Banking Corp. of Florida (SBCF), exercised 12,635 stock option/derivative shares at $31.15 per share (cost $393,580) on Feb 26, 2026, and sold the same 12,635 shares in the open market at a weighted average price of $32.90 per share (proceeds $415,692). The filings show both the exercise (acquisition) and the subsequent disposition of the underlying shares.

Key Details

Transaction date: February 26, 2026.
Exercise price/derivative conversion: $31.15 per share; total exercise cost reported $393,580.
Sale: 12,635 shares sold at a weighted average price $32.90; total proceeds $415,692. Footnote F1: sale executed in multiple transactions at prices ranging $32.89–$32.95.
Relevant footnotes: F6 indicates the options exercised were granted April 2, 2018 and vested over three years; F5 notes grants under the company's 2013 Incentive Plan. Filing references several unvested restricted stock awards (F2–F4) though those were not transacted here.
Shares owned after transaction: not specified in the provided filing details.
Timeliness: Form 4 filed Feb 27, 2026 for transactions on Feb 26, 2026 (appears timely).

Context

This is an option exercise followed by an immediate or near-immediate sale of the same shares (commonly called a cashless exercise or exercise-and-sell). That pattern typically reflects exercising vested options to cover the exercise cost/taxes rather than a standalone buy or directional bet. The filings are factual disclosures of insider activity and do not, by themselves, indicate the insider’s broader view of the company.

Form 4

Period: 2026-02-26

EVP & CRO

Transactions

Exercise/Conversion
Common Stock
2026-02-26$31.15/sh+12,635$393,580→ 55,027 total
Sale
Common Stock
[F1]
2026-02-26$32.90/sh−12,635$415,692→ 42,392 total
Exercise/Conversion
Common Stock Right to Buy
[F5][F6]
2026-02-26$31.15/sh−12,635$393,580→ 0 total
Exercise: $31.15Exp: 2028-04-01→ Common Stock (12,635 underlying)

Holdings

Footnotes (6)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.89 to $32.95. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction
[F2]Represents an unvested time-based restricted stock award granted on April 1, 2023, which shall vest over 3 years in one-third increments, beginning April 2, 2024, and on each anniversary thereafter, subject to continued employment
[F3]Represents an unvested time-based restricted stock award granted on April 1, 2024, which shall vest over 3 years in one-third increments, beginning April 1, 2025, and on each anniversary thereafter, subject to continued employment
[F4]Represents an unvested time based restricted stock award grated on April 1, 2025, which vests over 3 years in one-third increments, beginning April 1, 2026, and on each anniversary thereafter subject to continued employment
[F5]Granted pursuant to the Company's Amended and Restated 2013 Incentive Plan
[F6]Represents stock option granted on April 2, 2018 ("grant date") that vests over 3 years in one-third increments each anniversary of the date of grant beginning on the first anniversary of the date of grant, subject to continued employment

Signature

/s/ Kathy L. Hsu as Power of Attorney for Joseph M. Forlenza|2026-02-27

1 file